256 related articles for article (PubMed ID: 31840409)
21. Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion.
Minsky BD; Mies C; Recht A; Rich TA; Chaffey JT
Cancer; 1988 Apr; 61(7):1417-24. PubMed ID: 3345494
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the sigmoid take-off with other definitions of the rectosigmoid junction: A retrospective comparative cohort analysis.
Li F; Wang B; Lu S; Wang Y; Sun T; Wang H; Zhou X; Fu W
Int J Surg; 2020 Aug; 80():168-174. PubMed ID: 32650119
[TBL] [Abstract][Full Text] [Related]
23. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
[TBL] [Abstract][Full Text] [Related]
24. [The surgery of rectosigmoid cancer: 10 years of experience].
Di Cosmo L; Piccolomini A; Vuolo G; Fornasetti A
G Chir; 1990 Apr; 11(4):225-8. PubMed ID: 1699591
[TBL] [Abstract][Full Text] [Related]
25. [81 cancers of the rectosigmoid junction. Colonic or rectal neoplasms?].
Moutinho-Ribeiro M; de Sousa JP
Acta Med Port; 1993 Oct; 6(10):443-7. PubMed ID: 8285114
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
Law WL; Chu KW
J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
[TBL] [Abstract][Full Text] [Related]
27. Laparoscopic surgery for colorectal cancer with persistent descending mesocolon.
Hiyoshi Y; Miyamoto Y; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Baba H
World J Surg Oncol; 2019 Nov; 17(1):190. PubMed ID: 31711517
[TBL] [Abstract][Full Text] [Related]
28. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
[TBL] [Abstract][Full Text] [Related]
29. Location of rectal cancer within the circumference of the rectum does not influence lymph node status.
Ulrich A; Himmer K; Koch M; Kienle P; Büchler MW; Weitz J
Ann Surg Oncol; 2007 Aug; 14(8):2257-62. PubMed ID: 17520316
[TBL] [Abstract][Full Text] [Related]
30. Effect of Responsiveness of Lymph Nodes to Preoperative Chemoradiotherapy in Patients With Rectal Cancer on Prognosis After Radical Resection.
Lee HG; Kim SJ; Park IJ; Hong SM; Lim SB; Lee JB; Yu CS; Kim JC
Clin Colorectal Cancer; 2019 Jun; 18(2):e191-e199. PubMed ID: 31014994
[TBL] [Abstract][Full Text] [Related]
31. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
[TBL] [Abstract][Full Text] [Related]
32. Rectal Cancer in 2018: A Primer for the Gastroenterologist.
Goldenberg BA; Holliday EB; Helewa RM; Singh H
Am J Gastroenterol; 2018 Dec; 113(12):1763-1771. PubMed ID: 30008472
[No Abstract] [Full Text] [Related]
33. Increased Lymph Node Yield Is Associated With Improved Survival in Rectal Cancer Irrespective of Neoadjuvant Treatment: Results From a National Cohort Study.
Lykke J; Jess P; Roikjaer O;
Dis Colon Rectum; 2015 Sep; 58(9):823-30. PubMed ID: 26252843
[TBL] [Abstract][Full Text] [Related]
34. New lymph node staging for rectal neuroendocrine tumors.
Fields AC; McCarty JC; Ma-Pak L; Lu P; Irani J; Goldberg JE; Bleday R; Chan J; Melnitchouk N
J Surg Oncol; 2019 Jan; 119(1):156-162. PubMed ID: 30481376
[TBL] [Abstract][Full Text] [Related]
35. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy.
Abdel-Misih SR; Wei L; Benson AB; Cohen S; Lai L; Skibber J; Wilkinson N; Weiser M; Schrag D; Bekaii-Saab T
J Natl Compr Canc Netw; 2016 Dec; 14(12):1528-1534. PubMed ID: 27956537
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors.
Tsukamoto S; Fujita S; Yamaguchi T; Yamamoto S; Akasu T; Moriya Y; Taniguchi H; Shimoda T
Int J Colorectal Dis; 2008 Nov; 23(11):1109-13. PubMed ID: 18594844
[TBL] [Abstract][Full Text] [Related]
38. Rectal neuroendocrine and L-cell tumors: diagnostic dilemma and therapeutic strategy.
Lee SH; Kim BC; Chang HJ; Sohn DK; Han KS; Hong CW; Lee EJ; Lee JB; Lee DS; Lee IT; Youk EG
Am J Surg Pathol; 2013 Jul; 37(7):1044-52. PubMed ID: 23648459
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.
Chi Y; Du F; Zhao H; Wang JW; Cai JQ
World J Gastroenterol; 2014 Nov; 20(43):16252-7. PubMed ID: 25473180
[TBL] [Abstract][Full Text] [Related]
40. The rectosigmoid problem.
D'Souza N; de Neree Tot Babberich MPM; Lord A; Shaw A; Abulafi M; Tekkis P; Wiggers T; Brown G
Surg Oncol; 2018 Sep; 27(3):521-525. PubMed ID: 30217314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
